Supplementary Material - FNE

Published: 15 March 2024| Version 1 | DOI: 10.17632/fnsnk5kd3t.1
Contributors:
Christine Jo, Alexandra Finstad , Jorge-Ryan Georgakopoulos, Vincent Piguet, Jensen Yeung, Aaron Drucker

Description

Table S1: Full chart of included studies reporting facial and/or neck erythema with dupilumab use Table S2: Quality assessment for case reports/series Table S3: Funding sources of included studies References Prospero protocol PRISMA checklist

Files

Categories

Adverse Effect of Drug, Atopic Dermatitis

Licence